Correction to: Efficacy and Safety of Apixaban versus Dalteparin as a Treatment for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis (Medicina, (2023), 59, 10, (1867), 10.3390/medicina59101867)
Miguel A. Arce-Huamani*, Joshuan J. Barboza, José Fabián Martínez-Herrera, J. Smith Torres-Roman, Jorge L. Maguiña
Research output: Contribution to journal › Comment/debate
Fingerprint
Dive into the research topics of 'Correction to: Efficacy and Safety of Apixaban versus Dalteparin as a Treatment for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis (Medicina, (2023), 59, 10, (1867), 10.3390/medicina59101867)'. Together they form a unique fingerprint.